These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2992962)

  • 21. Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.
    Watling D; Serafinowska HT; Reese CB; Kerr IM
    EMBO J; 1985 Feb; 4(2):431-6. PubMed ID: 2410258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and biological activity of 8-substituted analogues of 2',5'-oligoadenylates.
    Nagai K; Kanbara K; Nakashima H; Yamamoto N; Suhadolnik RJ; Takaku H
    Biochim Biophys Acta; 1993 Mar; 1156(3):321-6. PubMed ID: 8461324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitogenic effects of interferon and (2'-5')-oligoadenylate in synchronized 3T3 fibroblasts.
    Kimchi A; Shure H; Lapidot Y; Rapoport S; Panet A; Revel M
    FEBS Lett; 1981 Nov; 134(2):212-6. PubMed ID: 6171460
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biological activities of pppA2'p5'A2'p5'A].
    Zhao XX; Hou YD; Su XL; Liu XY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Dec; 4(6):367-71. PubMed ID: 6303612
    [No Abstract]   [Full Text] [Related]  

  • 25. 5'-O-dephosphorylated 2',5'-oligoadenylate (2-5A) with 8-methyladenosine at the 2'-terminus activates human RNase L.
    Nagaoka K; Kitamura Y; Ueno Y; Kitade Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1186-8. PubMed ID: 20022497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically active 2-5A analogs containing 3'-O,4'-C-propylene adenosine as potent RNase L agonists.
    Morita K; Obika S; Imanishi T; Kitade Y; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):637-8. PubMed ID: 18776541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vaccinia mRNA methylation by 2',5'-linked oligo(adenylic acid) triphosphate.
    Sharma OK; Goswami BB
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2221-4. PubMed ID: 6166003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease.
    Floyd-Smith G; Slattery E; Lengyel P
    Science; 1981 May; 212(4498):1030-2. PubMed ID: 6165080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase.
    Cayley PJ; Davies JA; McCullagh KG; Kerr IM
    Eur J Biochem; 1984 Aug; 143(1):165-74. PubMed ID: 6088228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of RNase L overexpression on viral and cellular growth and death.
    Zhou A; Paranjape JM; Hassel BA; Nie H; Shah S; Galinski B; Silverman RH
    J Interferon Cytokine Res; 1998 Nov; 18(11):953-61. PubMed ID: 9858317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High yield synthesis, purification and characterisation of the RNase L activators 5'-triphosphate 2'-5'-oligoadenylates.
    Morin B; Rabah N; Boretto-Soler J; Tolou H; Alvarez K; Canard B
    Antiviral Res; 2010 Sep; 87(3):345-52. PubMed ID: 20547186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral activity towards VSV and Mengo virus of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P; Huez G; Verhaegen-Lewalle M; De Clercq E; Torrence P; Content J
    Prog Clin Biol Res; 1985; 202():141-6. PubMed ID: 3008170
    [No Abstract]   [Full Text] [Related]  

  • 33. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the RNA polymerase of vesicular stomatitis virus by ppp5'A2'p5'A and related compounds.
    Subramanian M; Kovacs T; Lesiak K; Torrence PF; Lenard J
    Antiviral Res; 1990 Feb; 13(2):81-9. PubMed ID: 2160797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologically stable 2-5A analogues containing 3'-O,4'-C-bridged adenosine as potent RNase L agonists.
    Morita K; Kaneko M; Obika S; Imanishi T; Kitade Y; Koizumi M
    ChemMedChem; 2007 Dec; 2(12):1703-7. PubMed ID: 17910011
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of poly(ADP-ribose) transferase activity by 2',5'-oligoadenylates.
    Pivazian AD; Suzuki H; Vartanian AA; Zhelkovsky AM; Farina B; Leone E; Karpeisky MYa
    Biochem Int; 1984 Aug; 9(2):143-52. PubMed ID: 6207831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody targeted liposomes containing poly(rI).poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma.
    Milhaud PG; Machy P; Lebleu B; Leserman L
    Biochim Biophys Acta; 1989 Dec; 987(1):15-20. PubMed ID: 2557080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.
    Hovanessian AG; Wood J; Meurs E; Montagnier L
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3261-5. PubMed ID: 114998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2',5'-Oligo(A)-activated endoribonuclease. Tissue distribution and characterization with a binding assay.
    Nilsen TW; Wood DL; Baglioni C
    J Biol Chem; 1981 Nov; 256(21):10751-4. PubMed ID: 7287731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of K+ concentration on inhibition of protein synthesis by trimer and tetramer triphosphates of 2',5'-oligoadenylates in rabbit reticulocyte lysates.
    Wu JM; Konno S; Eslami B
    Biochem Biophys Res Commun; 1985 Jul; 130(2):821-7. PubMed ID: 2411264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.